Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease

Journal of Clinical Gastroenterology

Volumn 49, Issue 3, 2015, Pages 212-217

  Singh, Prashant ^a   Kurray, Lalit ^a   Agnihotri, Abhishek ^a   Das, Prasenjit ^a   Verma, Anil Kumar ^a   Sreenivas, Vishnubhatla ^a   Dattagupta, Siddharth ^a   Makharia, Govind K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Enteropathy; Histology; Serology; Villous atrophy

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ADULT; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DUODENUM BIOPSY; FEMALE; GLUTEN FREE DIET; HUMAN; INDIAN; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; ATROPHY; BIOPSY; BLOOD; DIET THERAPY; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INDIA; MICROVILLUS; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; ATROPHY; AUTOANTIBODIES; BIOMARKERS; BIOPSY; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GTP-BINDING PROTEINS; HUMANS; INDIA; MALE; MICROVILLI; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84922695117     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000105     Document Type: Article

References (29)

1. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731-1743.
2. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136-160.
3. Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG Clinical Guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-676.
4. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther. 2008;27: 572-577.
5. Dahlbom I, Korponay-Szabó IR, Kovács JB, et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr. 2010;50:140-146.
6. Barker CC, Mitton C, Jevon G, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341-1346.
7. Mubarak A, Wolters VM, Gmelig-Meyling FH, et al. Tissue transglutaminase levels above 100U/mL and celiac disease: a prospective study. World J Gastroenterol. 2012;18:4399-4403.
8. Alessio MG, Tonutti E, Brusca I, et al. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr. 2012;55:44-49.
9. Donaldson MR, Book LS, Leiferman KM, et al. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol. 2008;42:256-260.
10. Singh P, Chaturvedi MK, Rangan P, et al. Patients of celiac disease with mild villous atrophy are clinically similar to those with moderate to severe atrophy. Indian J Gastroenterol. 2013;32:413-414.
11. Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894-900.
12. Akbari MR, Mohammadkhani A, Fakheri H, et al. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol. 2006;18:1181.
13. Saberi-Firouzi M, Omrani GR, Nejabat M, et al. Prevalence of celiac disease in Shiraz, southern Iran. Saudi J Gastroenterol. 2008;14:135-138.
14. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-1194.
15. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention, and control. A guide for programme managers (WHO/NHD/01.3). Geneva: World Health Organization; 2001.
16. Taavela J, Kurppa K, Collin P, et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol. 2013;11:166-171.
17. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473-478.
18. Gupta R, Reddy DN, Makharia GK, et al. Indian task force for celiac disease: current status. World J Gastroenterol. 2009;15:6028-6033.
19. Yadav P, Das P, Mirdha BR, et al. Current spectrum of malabsorption syndrome in adults in India. Indian J Gastroenterol. 2011;30:22-28.
20. Sakly W, Mankaï A, Ghdess A, et al. Performance of antideamidated gliadin peptides antibodies in celiac disease diagnosis. Clin Res Hepatol Gastroenterol. 2012;36:598-603.
21. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27:328-339.
22. Crenn P, Vahedi K, Lavergne-Slove A, et al. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003;124:1210-1219.
23. Curis E, Crenn P, Cynober L. Citrulline and the gut. Curr Opin Clin Nutr Metab Care. 2007;10:620-626.
24. Adriaanse MP, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther. 2013;37:482-490.
25. Moró n B, Verma AK, Das P, et al. CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease. Am J Gastroenterol. 2013;108:1344-1351.
26. Planas R, Pujol-Autonell I, Ruiz E, et al. Regenerating gene Ia is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study. Transl Res. 2011;158:140-145.
27. Isenberg DA, Manson JJ, Ehrenstein MR, et al. Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford). 2007;46:1052-1056.
28. Halttunen T, Mä ki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology. 1999;116:566-572.
29. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993;121: 439-448.